( 7-322-2565
Home
Biology
Medicine
Technology
Products
News
Definition
Dictionary
Movies
Links
Tags
Search
RSS
Navigation Links
Biology News
Medicine News
Biology Products
Medicine Products
Biology Definition
Medicine Definition
Biology Technology
Medicine Technology
Biology Dictionary
Medicine Dictionary
HOME
>>
MEDICINE
>>
TECHNOLOGY
ZIO-101 (Darinaparsin) Interim Phase II and Preclinical Data,Presented at International Myeloma Workshop
7-322-2565 a target _blank href mailto:tposterli@rxir.com tposterli@rxir.com
http://www.bio-medicine.org/inc/biomed/medicine-technology.asp
http://feeds.bio-medicine.org/latest-medical-technology
7-322-2565
tposterli@rxir.com
'"/>
Page:
1
2
3
4
Related medicine technology :
1
.
ZIOPHARM Presents Data Highlighting Oral ZIO-101 at AACR
2
.
Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
3
.
Positive ZIO-201 Interim Phase II Sarcoma Data Presented at European Society for Medical Oncology
4
.
Ablynx Announces Interim Results of First Nanobody Phase I Study of ALX-0081 (ANTI-VWF)
5
.
Based on Up to 6 Years of Follow-Up, Biovest Announces Favorable Interim Blinded Data for Fast-Tracked Pivotal Phase 3 Clinical Trial of BiovaxID Anti-Cancer Vaccine for Non-Hodgkins Lymphoma
6
.
Accentia Biopharmaceuticals Announces Favorable Interim Blinded Data on SinuNase in Its Fast-Tracked Pivotal Phase 3 Clinical Trial for Chronic Sinusitis
7
.
Pharmacyclics Announces Interim Results From Two Ongoing Phase 2 Trials Supporting Potential of Xcytrin Plus Chemotherapy to Treat Recurrent Non-Small Cell Lung Cancer
8
.
Interim Analysis of Crinone Pregnancy Study to Be Published in American Society for Reproductive Medicine Journal
9
.
Avalon Pharmaceuticals Announces Positive Interim Results For AVN944 Phase I Trial
10
.
Vical Interim Clinical Results Demonstrate Safety and Tolerability of Inovio Biomedicals Electroporation DNA Delivery Technology
11
.
Interim Data From RECORD Study Show No Significant Difference Between Avandia and Standard Therapy in Risk of Cardiovascular Hospitalization or Death
Post Your Comments:
*
Name:
*
Comment:
*
Email:
TAG:
ZIO
Darinaparsin
Interim
Phase
and
Preclinical
Data
Presented
International
Myeloma
Workshop
Breaking Medicine Technology:
Maxygen, Inc. Announces Extension of Dutch Auction Tender Offer 2
Within3 Expands into Mobile Applications 2
Published Data Demonstrate Arena Pharmaceuticals' Lorcaserin Has Low Abuse Potential 2
Published Data Demonstrate Arena Pharmaceuticals' Lorcaserin Has Low Abuse Potential 3
Published Data Demonstrate Arena Pharmaceuticals' Lorcaserin Has Low Abuse Potential 4
IDEV 28R 29 Technologies Announces First Patient Enrolled in Multi Center Clinical Trial of SUPERA 28R 29 PERipheral Stent 4886 1
IDEV 28R 29 Technologies Announces First Patient Enrolled in Multi Center Clinical Trial of SUPERA 28R 29 PERipheral Stent 4886 2
New Data Demonstrate Magnetic Resonance Safety of AQUACEL 28R 29 Ag Dressing 55129 1
New Data Demonstrate Magnetic Resonance Safety of AQUACEL 28R 29 Ag Dressing 55129 2
New Data Demonstrate Magnetic Resonance Safety of AQUACEL 28R 29 Ag Dressing 55129 3
New Data Demonstrate Magnetic Resonance Safety of AQUACEL 28R 29 Ag Dressing 55129 4
Zipcar Wraps Up Month Long Program Reveals Results of the 2009 Low Car Diet 55127 1
Zipcar Wraps Up Month Long Program Reveals Results of the 2009 Low Car Diet 55127 2
Zipcar Wraps Up Month Long Program Reveals Results of the 2009 Low Car Diet 55127 3
Zipcar Wraps Up Month Long Program Reveals Results of the 2009 Low Car Diet 55127 4
[
0
] Maxygen, Inc. Announces Extension of Dutch Auction Tender Offer
[
0
] Within3 Expands into Mobile Applications
[
0
] Published Data Demonstrate Arena Pharmaceuticals' Lorcaserin Has Low Abuse Potential
Other Medicine Technology:
Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity 2
Replidyne Phase II Pediatric Trial Meets Primary Objective 2
Replidyne Phase II Pediatric Trial Meets Primary Objective 3
Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
Replidyne Phase II Pediatric Trial Meets Primary Objective
Breaking Medicine News(10 mins):
Health News:Tweaks to Breast Cancer Treatments Boost Outcomes 2
Health News:Tweaks to Breast Cancer Treatments Boost Outcomes 3
Health News:Scientific panel evaluates soy infant formula safety 2
Health News:The Visiting Nurse Association of Greater Philadelphia Expands Service to Bucks County 2
Health News:'Disease of Poverty': University of South Carolina Releases Journal on Cervical Cancer, Health Disparities 2
Health News:'Disease of Poverty': University of South Carolina Releases Journal on Cervical Cancer, Health Disparities 3
[
0
] Tweaks to Breast Cancer Treatments Boost Outcomes
[
0
] Scientific panel evaluates soy infant formula safety
[
0
] Many Stroke Survivors Don't Take Lifesaving Meds
[
0
] The Visiting Nurse Association of Greater Philadelphia Expands Service to Bucks County
[
0
] 'Disease of Poverty': University of South Carolina Releases Journal on Cervical Cancer, Health Disparities
Other Medicine News:
Health News:The Female Health Company Reports First Quarter Operating Results, as Gross Profit Margins Widen on Increasing Sales of FC2 Female Condom(R) 2
Health News:The Female Health Company Reports First Quarter Operating Results, as Gross Profit Margins Widen on Increasing Sales of FC2 Female Condom(R) 3
Health News:The Female Health Company Reports First Quarter Operating Results, as Gross Profit Margins Widen on Increasing Sales of FC2 Female Condom(R) 4
Health News:The Female Health Company Reports First Quarter Operating Results, as Gross Profit Margins Widen on Increasing Sales of FC2 Female Condom(R) 5
Health News:The Female Health Company Reports First Quarter Operating Results, as Gross Profit Margins Widen on Increasing Sales of FC2 Female Condom(R) 6
Health News:The Female Health Company Reports First Quarter Operating Results, as Gross Profit Margins Widen on Increasing Sales of FC2 Female Condom(R) 7
Health News:Cambridge Healthtech Media Group Launches Clinical Trials Web Site 2
Health News:Cambridge Healthtech Media Group Launches Clinical Trials Web Site 3
Health News:MainConcept Releases New Codec SDK 8.0 2
Health News:MainConcept Releases New Codec SDK 8.0 3
Health News:MainConcept Releases New Codec SDK 8.0 4
Health News:Aetna Now Covers Novasys Medical's Renessa(R) Treatment for Incontinence in Women 2
Health News:China Medical Technologies to Announce Financial Results for the Third Fiscal Quarter Ended December 31, 2008 on March 2, 2009 2
Health News:Nothing But Nets and Union of Reform Judaism Help Save Lives in Kenya 2
The Female Health Company Reports First Quarter Operating Results, as Gross Profit Margins Widen on Increasing Sales of FC2 Female Condom(R)
Cambridge Healthtech Media Group Launches Clinical Trials Web Site
MainConcept Releases New Codec SDK 8.0
Aetna Now Covers Novasys Medical's Renessa(R) Treatment for Incontinence in Women
China Medical Technologies to Announce Financial Results for the Third Fiscal Quarter Ended December 31, 2008 on March 2, 2009
Nothing But Nets and Union of Reform Judaism Help Save Lives in Kenya
Medicine Products:
NMR LipoProfile
NMP22
Nitrogen Total, Urine
Nitrofurantoin, Serum or Plasma
Biology Navigation
AIDS/HIV
Bioinformatics
Biotechnology
Biochemistry
Cancer
Cell Biology
Developmental Biology
Ecology
Environment
Evolution
Food Technology
Gene
Genetics
Genomics
Health/Medicine
Immunology
Microarray
Microbiology
Molecular
Marine Biology
Nanobiotechnology
Neurobiology
Plant Sciences
Stem Cell
Systems Biology
Virus
Women Health
Medical Navigation
Abortion
Aches
ADHD
Addiction
Alcohol
Allergy
Alternative Medicine
Alzheimer's Dementia
Anxiety/Stress
Arthritis
Autism
Bacteria
Blood
Bird Flu/Avian Flu
Bones
Breast Cancer
Cancer
Cardiovascular
Cervical Cancer
Chikungunya
Cholesterol
Clinical Trials
Colorectal Cancer
Conferences
Crohn's
Cystic Fibrosis
Dengue
Dentistry
Depression
Diabetes
Drug
Eating Disorders
Education
Epilepsy
Erectile Dysfunction
Eye Health/Blindness
Fertility
Flu/Cold
GastroIntestinal
Genetics
Gout
Headache/Migraine
Hearing/Deafness
HIV/AIDS
Huntington's Disease
Hypertension
Immune System/Vaccines
Insurance
Infectious Diseases
Irritable-Bowel Syndrome
Internet
Leukemia
Lifestyle
Liver Disease/Hepatitis
Lung Cancer
Lupus
Mad Cow Disease
Medical Devices
Medical Students/Training
Medicare/Medicaid
Medico
Men's health
Mental Health
MRI/Ultrasound
MRSA/Drug Resistance
Multiple Sclerosis
Muscular Dystrophy
Neurology
Nursing
Nutrition/Diet
Obesity/Weight Loss
Pain/Anesthetics
Parkinson's Disease
Pediatrics/Children's Health
Pharma/Biotech Industry
Pharmacy/Pharmacists
Pregnancy
Premature
Prostate
Psychology/Psychiatry
Rehabilitation
Respiratory/Asthma
SARS
Schizophrenia
Seniors/Aging
Sexual Health
Sleep/Sleep Disorders
Smoking
Statins
Stem Cell Research
Stroke
Surgery
Transplants/Organ Donations
Viruses
Water - Air Quality
Women's Health